Emerald Mutual Fund Advisers Trust Neogenomics Inc Transaction History

Emerald Mutual Fund Advisers Trust

$1.23 Billion
Q1 2025

A detailed history of Emerald Mutual Fund Advisers Trust transactions in Neogenomics Inc stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 654,281 shares of NEO stock, worth $4.67 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

654,281

Previous 1,067,400 38.7%

Holding current value

$4.67 Million

Previous $17.6 Million 64.7%

% of portfolio

0.5%

Previous 1.21%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$9.09 - $18.61 $3.76 Million - $7.69 Million	-413,119 Reduced 38.7%	654,281 $6.21 Million
Q4 2024 Feb 14, 2025	SELL	$13.0 - $18.43 $2.16 Million - $3.06 Million	-166,165 Reduced 13.47%	1,067,400 $17.6 Million
Q3 2024 Oct 29, 2024	SELL	$13.4 - $17.73 $4.21 Million - $5.57 Million	-314,330 Reduced 20.31%	1,233,565 $18.2 Million
Q2 2024 Aug 06, 2024	SELL	$13.01 - $15.77 $130,100 - $157,700	-10,000 Reduced 0.64%	1,547,895 $21.5 Million
Q3 2023 Oct 26, 2023	BUY	$12.15 - $17.85 $2.22 Million - $3.27 Million	183,112 Added 13.32%	1,557,895 $19.2 Million
Q1 2023 May 04, 2023	SELL	$9.09 - $19.45 $2.54 Million - $5.44 Million	-279,760 Reduced 16.91%	1,374,783 $23.9 Million
Q4 2022 Feb 03, 2023	BUY	$6.45 - $12.07 $5.72 Million - $10.7 Million	886,357 Added 115.38%	1,654,543 $15.3 Million
Q3 2022 Oct 25, 2022	SELL	$7.86 - $12.91 $1.51 Million - $2.47 Million	-191,672 Reduced 19.97%	768,186 $6.61 Million
Q2 2022 Jul 29, 2022	SELL	$7.06 - $13.97 $6,876 - $13,606	-974 Reduced 0.1%	959,858 $7.82 Million
Q1 2022 Apr 29, 2022	SELL	$12.15 - $35.28 $549,860 - $1.6 Million	-45,256 Reduced 4.5%	960,832 $11.7 Million
Q4 2021 Feb 02, 2022	BUY	$30.49 - $48.49 $220,442 - $350,582	7,230 Added 0.72%	1,006,088 $34.3 Million
Q2 2021 Jul 29, 2021	SELL	$36.62 - $51.69 $6.98 Million - $9.85 Million	-190,654 Reduced 16.03%	998,858 $45.1 Million
Q1 2021 Apr 29, 2021	SELL	$41.56 - $59.88 $552,955 - $796,703	-13,305 Reduced 1.11%	1,189,512 $57.4 Million
Q4 2020 Jan 29, 2021	SELL	$36.08 - $56.47 $3.86 Million - $6.03 Million	-106,851 Reduced 8.16%	1,202,817 $64.8 Million
Q2 2020 Jul 28, 2020	BUY	$24.21 - $31.02 $2.78 Million - $3.56 Million	114,653 Added 9.59%	1,309,668 $40.6 Million
Q1 2020 Apr 30, 2020	SELL	$20.5 - $34.53 $5.19 Million - $8.74 Million	-253,233 Reduced 17.49%	1,195,015 $33 Million
Q4 2019 Jan 29, 2020	SELL	$18.96 - $29.84 $6.26 Million - $9.86 Million	-330,282 Reduced 18.57%	1,448,248 $42.4 Million
Q3 2019 Oct 31, 2019	SELL	$19.12 - $26.24 $1.67 Million - $2.29 Million	-87,229 Reduced 4.68%	1,778,530 $34 Million
Q2 2019 Jul 31, 2019	SELL	$19.57 - $24.1 $195,700 - $241,000	-10,000 Reduced 0.53%	1,865,759 $40.9 Million
Q1 2019 May 01, 2019	BUY	$12.14 - $20.46 $502,474 - $846,839	41,390 Added 2.26%	1,875,759 $38.4 Million
Q4 2018 Jan 31, 2019	BUY	$11.24 - $18.5 $3.12 Million - $5.14 Million	277,624 Added 17.83%	1,834,369 $23.1 Million
Q3 2018 Oct 31, 2018	BUY	$12.5 - $15.38 $13.9 Million - $17.1 Million	1,112,939 Added 250.77%	1,556,745 $23.9 Million
Q2 2018 Jul 31, 2018	BUY	$7.99 - $14.05 $1.29 Million - $2.27 Million	161,300 Added 57.1%	443,806 $5.82 Million
Q1 2018 Apr 26, 2018	SELL	$7.23 - $8.76 $6.58 Million - $7.97 Million	-910,095 Reduced 76.31%	282,506 $2.31 Million
Q4 2017 Feb 06, 2018	BUY	$8.02 - $11.18 $601,868 - $839,014	75,046 Added 6.72%	1,192,601 $10.6 Million
Q3 2017 Oct 30, 2017	BUY	$9.11 - $11.26 $10.2 Million - $12.6 Million	1,117,555	1,117,555 $12.4 Million

Others Institutions Holding NEO

# of Institutions

288

Shares Held

127M

Call Options Held

942K

Put Options Held

172K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $897M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Account

Emerald Mutual Fund Advisers Trust Neogenomics Inc Transaction History